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Simultaneous determination of enantiomers of structurally related
anticholinergic analogs in human serum by liquid chromatography–
electrospray ionization mass spectrometry with on-line sample
cleanup
ˇ´
´ Capk
Vladimır
, Yan X

Introduction
Trihexyphenidyl
(THP),
procyclidine
and
biperiden (Fig. 1) are anticholinergic drugs administered as racemates for the treatment of Parkinson’s
disease and extrapyramidal side effects of neuroleptics [1–4]. Anticholinergic drugs compete with the
neurotransmitter acetylcholine for its receptor sites at

synaptic junctions, which consequently leads to
inhibition of transmission of certain nerve impulses.
Side effects of THP include bradycardia, disturbances of recent memory, and myasthenia gravis.
Among psychotic patients, it demonstrated hallucinogenic and euphoric properties that led to its
frequent abuse either alone or in the combination
with other opiates and narcotics [5]. Other side
effects of common anticholinergic drugs include
blurred vision, constipation, dryness of the mouth,
mental disturbances, slurred speech, and urinary
urgency or retention [6]. Understanding the clinical
pharmacology of these drugs is the first step toward
the elimination of these adverse side effects.
It has been long recognized that receptor-binding
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Fig. 1. Chemical structures of trihexyphenidyl, procyclidine, biperiden and diphenidol (I.S.).

sites in biological systems are often asymmetrical
and therefore capable of discriminating between
optical isomers of chiral drugs [7]. Consequently,
two enantiomers of a racemic drug may have different pathways of their absorption, distribution, and
metabolism in human body. Hence, these enantiomers can have different activity and toxicity in the
body. It is not unusual in clinical pharmacology that
one enantiomer of a drug is more potent than the
other, or one has a therapeutic effect whereas the
other has serious adverse drug reactions [8]. It was
indicated by previously published studies [7,9–15]
that (R)-enantiomers of THP and procyclidine have
significantly higher affinities for muscarinic receptor
subtypes than the corresponding (S)-enantiomers,
and the binding patterns of their (R)- and (S)-enantiomers are different. In case of biperiden, it was
shown that (1)-enantiomer was able to differentiate
at least three populations of muscarinic receptor
subtypes whereas (2)-enantiomer was nearly devoid
of such selectivity [16]. However, these studies
showed no conclusions about the potency of the
‘‘high affinity’’ enantiomer because no correlation
was observed between its potency and the affinity
ratios of the two enantiomers [7,10]. This situation
was in part due to the lack of sensitive stereoselective analytical methodology for the determination of
these enantiomers in biological fluids.
In this work, we present an analytical method for
the simultaneous determination of enantiomers of
THP, procyclidine and biperiden in human serum by
liquid chromatography–electrospray ionization mass
spectrometry (LC–ESI-MS) with on-line sample
extraction. The method employs a column-switching
technique [17–24] to streamline the on-line sample

preparation with LC–ESI-MS chiral analysis. Online sample preparation is accomplished using a
‘‘semi-permeable surface’’ (SPS) C 18 cartridge column for exclusion of serum proteins and retention of
drug molecules. The elution of drugs to LC–ESI-MS
system is accomplished by changing elution strength
of the mobile phase. The drug molecules are then
separated on a b-cyclodextrin (b-CD) column into
their individual enantiomers based on the improvement of our recent work [25]. Quantitation is done
by ESI-MS in the selected ion monitoring (SIM)
mode. The entire analysis can be automated and
requires little operator skill. We believe that the
method developed provides a useful analytical method for the determination of enantiomers of THP,
procyclidine, and biperiden in human serum. It can
be used in pharmacological, forensic and toxicological studies where the simultaneous determination of
multi-drug mixtures is required.

Experimental
Materials
DL-Trihexyphenidyl
hydrochloride, DL-procyclidine hydrochloride, diphenidol hydrochloride, ammonium acetate (.98%), acetonitrilie (HPLC grade)
and methanol (HPLC grade) were from Sigma (St.
Louis, MO, USA). Glacial acetic acid (HPLC grade)
was from J.T. Baker (Phillipsburgh, NJ, USA).
Triethylamine (TEA, .99%) was from Aldrich
(Milwaukee, WI, USA). DL-Biperiden hydrochloride
was donated by Knoll Pharmaceutical (Mount Olive,
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NJ, USA). Control human serum (catalog No.
2930149) was from ICN (Costa Mesa, CA, USA).
Deionized water was obtained from a NANOpure
water system (Branstead / Thermolyne, Dubuque, IA,
USA). Standard aqueous solutions of procyclidine,
THP, biperiden, and diphenidol were prepared by
dissolving appropriate amounts of solid compounds
in deionized water and serially diluting the resulting
solutions with deionized water. Standard solutions
for chiral separation optimization were prepared by
dissolving appropriate amounts of solid compounds
in the analytical column mobile phase and appropriate dilutions of the resulting solutions with the
analytical column mobile phase.
In this work, the analytical column mobile phase
was filtered through a Fluoropore PTFE membrane
(type FH, 0.5-mm pore) filter (Millipore, Bedford,
MA, USA) prior to use. Standard solutions prepared
in the analytical column mobile phase were filtered

through Whatman nylon syringe filters (sterile, 4
mm, 0.2-mm pore) from Fisher (Itasca, IL, USA). All
serum and aqueous solutions were filtered through
Corning cellulose acetate syringe filters (sterile, 47
mm, 0.45 mm pore) from Fisher as well.
Instrumentation
The column-switching setup used for this work is
schematically shown in Fig. 2. It included two HPLC
systems (one for on-line sample extraction, and the
other for chiral separation and detection). These
systems were connected via a Rheodyne 7000 twoposition six-port switching valve (Supelco, Bellefonte, PA, USA). The on-line sample extraction
system consisted of a GP 40 gradient LC pump
(Dionex, Sunnyvale, CA, USA), a HP 1100 autosampler (Hewlett-Packard, San Fernando, CA, USA),
and an SPS pre-column (C 18 , 1033.0 mm, Regis

Fig. 2. Schematic diagram of the column-switching setup. Position A: on-line sample extraction; position B: chiral separation and MS
detection. Solid line, the flow path of the extraction mobile phase (0.05 M NH 4 Ac in 10% CH 3 CN in water, 1.0 ml / min). Dashed line, the
flow path of the LC–MS mobile phase (CH 3 CN–CH 3 OH–HAc–TEA, 95:5:0.5:0.3, v / v, 0.25 ml / min).
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Technologies, Morton Grove, IL, USA). The LC–
MS (UV) system used for chiral separation and
detection consisted of a HP 1100 binary LC gradient
pump, a HP 1100 variable-wavelength UV detector,
a Cyclobond I 2000 native b-CD phase analytical
column (25032.0 mm, Advanced Separation Technologies, Whippany, NJ, USA), an ultra-low dead
volume stainless steel in-line filter (0.5-mm pore,
0.23-ml dead volume, Upchurch Scientific, Oak
Harbor, WA, USA), and a Quattro II triple quadrupole mass spectrometer with a MassLynx data
acquisition system from Micromass (Manchester,
UK).
The connection of the analytical column to the MS
detector was via a Valco (Houston, TX, USA)
stainless steel splitting tee (1 / 16 in.30.25 mm; 1
in.52.54 cm) at a post-column split ratio of 1:8. The
split ratio was adjusted by the resistance of the two
outgoing lines with the smaller flow connected to the
MS detector and the larger one to the UV detector.
For all the connections, high-pressure polyether ether
ketone (PEEK) tubing (1 / 16 in. O.D.) was used.
0.01 in. I.D. tubing was used for the on-line sample
extraction system, and 0.005 in. I.D. for the LC–MS
system.
On-line sample extraction and LC chiral
separation
An SPS pre-column was used for the on-line
sample extraction. Human serum containing DL-trihexyphenidyl hydrochloride, DL-biperiden hydrochloride, DL-procyclidine hydrochloride, and diphenidol
hydrochloride (internal standard, I.S.) or an aqueous
mixture of the standard solutions was first filtered
using a cellulose-acetate syringe filter. Then, a 50-ml
portion of the sample was injected by the autosampler onto the SPS pre-column with a mobile
phase of 0.05 M NH 4 Ac (pH 6.98) in 10% (v / v)
CH 3 CN at a flow-rate of 1 ml / min, and the switching valve in position A (Fig. 2). After 4-min sample
extraction and cleanup, the mobile phase was
changed to CH 3 CN–CH 3 OH–HAc–TEA (95:5:
0.5:0.3, v / v), and the flow-rate was reduced to 0.25
ml / min by switching the valve to the position B
(Fig. 2). The drugs and the internal standard were
eluted from the pre-column and separated in the
b-CD analytical column by the same mobile phase.

The valve was switched back to the position A at 15
min after the injection, and the pre-column was
equilibrated by pumping the mobile phase of 0.05 M
NH 4 Ac (pH 6.98) in 10% (v / v) CH 3 CN at a flowrate of 1 ml / min until the next injection.
ESI-MS detection
The MS detector was operated in the positive
electrospray ionization (ESI1) mode. It was tuned
by infusion of a mixture of analytes in analytical
column mobile phase (at 170 mg / ml for THP, 167
mg / ml for procyclidine, 167 mg / ml for biperiden,
and 84 mg / ml for diphenidol) with a Harvard
syringe pump (Harvard Apparatus, South Natick,
MA, USA) at a flow-rate of 3 ml / min via a 75-mm
I.D. fused-silica capillary. The ionization conditions
were: nitrogen desolvation gas at 300 l / h, capillary
at 3.00 kV, cone at 240 V, skimmer at 5 V, radio
frequency (RF) lens at 0.5 V, ion source temperature
at 708C, low- and high-mass resolution at 15, ion
energy at 1.6 V, and photomultiplier at 2650 V.
Full scan spectra were acquired in the continuum
mode over the mass range of 200–400 u at the scan
speed of 200 u / s. Selected-ion monitoring (SIM)
mode was used for quantitation by sequentially
monitoring quasi-molecular ions of each analyte (m /
z 288 [procyclidine1H] 1 , m /z 302 [THP1H] 1 , m /z
310 [I.S.1H] 1 , and m /z 312 [biperiden1H] 1 ). Data
acquisition was done with a dwell time of 0.5 s, one
replicate for each data point, and an inter-scan delay
of 0.02 s. Ionization parameters used were the same
as those described above.
The MS–MS detection mode (MRM) was also
examined. The MRM data acquisition was based on
mass fragmentation reactions of each parent ion (e.g.,
m /z 288 for procyclidine, m /z 302 for THP, m /z 310
for the I.S., and m /z 312 for biperiden). The ionization conditions of MRM mode were the same as
those used in SIM data acquisition mode (see
earlier). In order to find appropriate mass fragmentation reactions, daughter spectra were acquired in
continuum mode over the mass range of 50–350 u
with the scan speed of 300 u / s. The low- and
high-mass resolution was 10 for the first quadrupole
and 15 for the third. The collision gas was Ar at a
pressure of 2.6?10 23 mbar. The resulting spectra
were averaged over 2-min time windows. The MRM
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data acquisition was done with the dwell time of 0.5
s, inter-scan delay time of 0.02 s, and collision
energy of 20 eV for each acquisition function. Mass
fragmentation reactions used for MRM data acquisition were m /z 288→m /z 84 for procyclidine, m /z
302→m /z 98 for THP, m /z 310→m /z 129 for the
I.S., and m /z 312→m /z 98 for biperiden.
Preparation of samples and standard serum
solutions
Serum standard and sample solutions were prepared by spiking the mixed aqueous analyte standards to the blank human serum and subsequent
serial dilutions with blank human serum. Final serum
solutions were spiked with I.S aqueous solution in
the ratio of 20 / 1 (serum / I.S. solution) to produce 50
ng / ml concentration of I.S. in serum. Each serum
sample / standard contained at least 95% of serum
matrix. After vortex-mixing, each serum solution
was filtered through a cellulose acetate syringe filter
(sterile, 47 mm, 0.45 mm pore) and transferred to an
autosampler vial.

Results and discussion
On-line sample cleanup
An SPS pre-column [16,18,24] was chosen in this
work for on-line sample cleanup based on the
structures and polarity of the analytes. According to
the manufacturer, the SPS pre-column contains internal and external stationary phases. The internal phase
(inside the packing material pores) is a C 18 phase
that retains the hydrophobic analytes whereas the
external phase (outside the packing material pores) is
a hydrophilic polyoxyethylene that excludes the
serum proteins through a combination of electrostatic
repulsion and size exclusion. This design permits
permeation of small analyte molecules to the internal
stationary phase.
The mobile phase composition used for on-line
sample extraction must not denature the serum
proteins in the sample matrix. Generally, this means
that the amount of organic solvent in the mobile
phase should be limited to 15% or less (depending
on the solvent). The aqueous portion of the mobile

phase should contain a buffer with pH close to the
physiological value. Furthermore, the mobile phase
should have weak elution strength in order to retain
the analytes on column. When the hydrophobic
analytes interact with the C 18 internal phase, they
tend to be retained inside the packing material pores,
allowing them to separate from the protein sample
matrix.
In this work, both organic modifier and buffer
concentration were optimized. Mobile phases for
column-switching techniques are commonly based
on phosphate buffer due to its compatibility with the
biological matrix [17–21,26]. However, phosphate
buffer is incompatible with ESI-MS detection; hence,
NH 4 Ac buffer was used as the extraction buffer in
this work. CH 3 CN was chosen as the organic
modifier because it was also the major component of
the mobile phase used for chiral separation on the
analytical column. The CH 3 CN content was varied
from 0 to 15% by the volume, and the NH 4 Ac
concentrations of 0.05 and 0.1 M at pH 6.98 were
tested. Our experiments indicated that higher content
of CH 3 CN resulted in faster exclusion of the serum
proteins from the SPS pre-column. However, at 15%
CH 3 CN, an increased system pressure was observed
indicating a partial denaturing of serum proteins on
the pre-column. As compared with 0.1 M NH 4 Ac in
10% CH 3 CN, 0.05 M NH 4 Ac in 10% CH 3 CN
resulted in longer retention of the analytes, which is
desirable for sample cleanup. Therefore, 0.05 M
NH 4 Ac at pH 6.98 in 10% CH 3 CN was used for as
the mobile phase for the subsequent on-line sample
cleanup.
The column-switching time is an important parameter in any on-line sample cleanup approach. If a
premature switching time was used, the high organic
content mobile phase used for chiral separation on
the analytical column would denature remaining
serum proteins in the pre-column and result in
column clogging. In this work, the column-switching
time was determined by the experiments shown in
Fig. 3. Without the analytical column, the serum
protein matrix eluted within 1 min and the analytes
did not start to elute from the pre-column until 4.5
min using of 0.05 M NH 4 Ac (pH 6.98) in 10%
CH 3 CN as the mobile phase. Based on these results,
the column-switching time for the subsequent analysis was chosen to be 4 min after sample injection
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Fig. 3. UV chromatograms of analyte mixture (top trace) and control human serum (bottom trace). Analyte concentration, 126 mg / ml water
for each drug hydrochloride; instrumentation, the same as that shown in Fig. 2 without the b-CD column; UV detection at 258 nm.

when the analytes still be retained on the SPS precolumn.
The effectiveness of the analytical column mobile
phase for the elution of serum analytes from the SPS
pre-column is shown in Fig. 4. In this experiment,
50-ml samples were injected onto the SPS pre-column with the switching valve in the position A. At
4.0 min, the system was switched to the position B,
and the eluate from the pre-column was collected
and analyzed by ESI-MS. Mass spectra of fractions
collected during the 4-min time interval after the
column switching showed that all analytes were
present. Furthermore, there was no significant difference between peak intensities (as indicated by the
intensity of the highest peak) of the corresponding
analyte molecular peaks for the serum sample compared to the aqueous sample. This indicates that the
analytical column mobile phase was indeed effective
for eluting the analytes of interest from the precolumn regardless the presence of serum protein in
the sample matrix (see Table 2 for the recoveries of
each individual analyte). In this work, the analyticalcolumn mobile phase not only eluted the analytes
from the SPS pre-column, but also cleaned the precolumn prior to the valve switching back to the
position B.
The column-switching system shown in Fig. 2 was

tested in both ‘‘back-flush’’ and ‘‘forward-flush’’
mode. In the ‘‘back-flush’’ mode, the direction of
flow of the chiral separation mobile phase through
the pre-column is opposite to that of on-line sample
cleanup. This approach is suitable for analytes that
are strongly retained at the front portion of the
pre-column. Better peak shapes may be obtained
since analytes do not have to travel through the
entire pre-column after the switching. The ‘‘forwardflush’’ mode is suitable for analytes that migrate
further inside the pre-column during the sample
cleanup step. In this work, the ‘‘forward-flush’’ mode
was chosen because the column-switching time
chosen was close to the initial elution of the analytes.
LC–ESI-MS
Due to the structural similarity between THP and
other analytes in this work, a Cyclobond I 2000
native b-CD column [25] was chosen for their chiral
separations. The separation conditions developed for
THP enantiomers [25] were applied for the enantiomeric separation of procyclidine and biperiden with
minor modification. In order to bring the retention
times of procyclidine and biperiden to an acceptable
level (less than 30 min), the mobile phase composition was changed from previously reported
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Fig. 4. Mass spectra of the elution fractions from the SPS pre-column after completion of sample extraction. Fractions collected during
4-min time interval starting at the time of switching; analyte concentrations, 170 mg / ml for THP?HCl, 167 mg / ml biberiden?HCl and
procyclidine?HCl, and 84 mg / ml for diphenidol?HCl.

CH 3 CN–CH 3 OH–HAc–TEA (95:1:0.5:0.3, v / v)
[25] to CH 3 CN–CH 3 OH–HAc–TEA (95:5:0.5:0.3,
v / v).
Fig. 5 shows the mass chromatograms of
procyclidine, biperiden, THP and diphenidol (I.S.)
acquired in both SIM, and MRM modes. In SIM
mode, the quantitation ions were m /z of 288, 312,
302, and 310 for procyclidine, biperiden, THP and
diphenidol, respectively. In MRM mode, the mass
fragmentation reactions monitored were 288→84,
312→98, 302→98, and 310→129 for procyclidine,
biperiden, THP and diphenidol, respectively. For all
the parent ions, the maximal intensities of daughter
ions were achieved at the collision energy of 20 eV.

As seen in Fig. 5, the signal-to-noise (S /N) ratios
in this work were greater in SIM mode than that in
MRM mode, which were on the contrary to many
LC–MS applications. Generally, even though MRM
does not increase the analyte signals, it can eliminate
most of the chemical background and result in an
improved S /N ratio. In SIM mode, the added selectivity of the third quadrupole is taken away; therefore, the S /N ratio is usually smaller in SIM mode
than that of MRM mode. The explanation of our
observation come from the design of the Micromass
Quattro II ESI triple-quadrupole MS. The instrument
has two mass detectors, the first one located at the
end of the first quadrupole and the second one
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Fig. 5. LC–ESI-MS chromatograms of procyclidine, biperiden, THP, and diphenidol acquired in MRM mode (the top four traces) and in
SIM mode (the bottom four traces). Analyte enantiomer concentrations, 50 ng / ml for each drug hydrochloride in the analytical column
mobile phase.

behind the third quadrupole. Most ESI-MS–MS
systems in use contain only one detector located
behind the third quadrupole. When such a singledetector system is used, the partial loss of ions
caused by ion transmissions from first to the second
and third qudrupoles is compensated by a dramatic
decrease of chemical background in MRM mode.
Therefore, improved S /N ratio is observed. However, in the case of two-detector system used in this
work, the first detector was used for SIM mode, and

the second detector was used for MRM mode.
Consequently, the analyte ion trajectories in SIM
mode were shorter than those in MRM mode, and
the losses of ions due to collisions with the residual
gas molecules during their transmission from the first
to the third quadrupole were eliminated. Therefore,
the S /N ratios were greater in the SIM mode in our
case.
The fact that the sensitivity gain due to the
decrease of background in MRM mode did not
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outweigh the sensitivity gain caused by the shorter
ion trajectory in SIM mode suggests that the background noise in Fig. 5 was of electronic rather than
chemical nature. In this work, SIM mode was used
for the final method validation. It is worth noting that
in the case of insufficient sample cleanup, the
chemical noise can outweigh the electronic one, and
the MRM mode may be more appropriate for
quantitation (so as in the case of single-detector
MS–MS system).
Analytical performance
Quantitative analysis of THP, procyclidine and
biperiden was carried out using diphenidol as an
internal standard. Diphenidol is an achiral antiemetic drug structurally similar to the analytes (Fig.
1). Prior to the analysis, the internal standard was
added to the serum samples containing analytes. The
serum samples were then cleaned-up on-line and
analyzed by LC–ESI-MS in the SIM mode. A
representative chromatogram of serum sample is
shown in Fig. 6. All drug enantiomers were stereochemically resolved. Although these drugs were not

completely time-resolved from each other due to
their structural similarity, they were readily quantified by exploiting the mass selectivity of the SIM
mode of ESI-MS detection.
According to Desage et al. [1], the maximal
therapeutic plasma concentration of THP after a
single 15-mg dose was 55 ng / ml. Postmortem THP
concentrations after a 20-mg oral dose were found to
be as high as 380 ng / ml in urine [27]. For biperiden,
a 20-mg dose can produce blood concentration levels
approximately 50 ng / ml [27]. In the case of
procyclidine, the steady state blood concentrations of
150–630 ng / ml were reported. In overdosing and
drug abuse, the postmortem procyclidine concentrations of 4–4.4 mg / ml in blood, 11–15 mg / ml in
liver, and 1.8–7 mg / ml in urine were previously
reported [27]. It should be pointed out that some of
these concentration levels were determined after a
single oral dose of drug was administered. The
steady-state concentrations of these drugs would be
higher.
Table 1 shows the regression parameters of internal calibrations for THP, biperiden and procyclidine
enantiomers. As indicated by the correlation co-

Fig. 6. A representative LC–ESI-MS chromatogram of serum sample. Analyte enantiomer concentration, 50 ng / ml in serum for each drug
hydrochloride.
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Table 1
Regression parameters of internal calibration curves for enantiomers of THP, biperiden and procyclidine (n56; confidence level595%;
calibration range: 11–600 ng / ml)
Compound

Regression equation
24

Correlation coefficient

THP

First peak
Second peak

y50.0167 (62.4?10 )x20.005 (60.064)
y50.0157 (62.4?10 24 )x10.006 (60.062)

0.9996
0.9996

Biperiden

First peak
Second peak

y50.0095 (66.5?10 25 )x20.000 (60.017)
y50.0082 (61.1?10 24 )x20.007 (60.029)

0.9999
0.9996

Procyclidine

First peak
Second peak

y50.0146 (69.1?10 25 )x10.010 (60.024)
y50.0126 (68.1?10 25 )x20.001 (60.021)

0.9999
0.9999

efficients ($0.9996), the method shows excellent
linearity within the calibration ranges of 11–600
ng / ml. In fact, the linearity of the method was
evaluated up to 1140 ng / ml and the calibration
curves still showed good correlation coefficients
(.0.99). The detection limits of the method (defined
as concentration at S /N53) were determined to be 1
ng / ml. The detection limits may be further improved
by injecting larger sample volumes onto the SPS
pre-column. Injection volumes up to 500 ml were
reported with some ‘‘restricted access media’’ without significant band broadening [18,19,21]. According to the aforementioned studies [18,19,21], total
plasma volume of 50 ml or more could be injected
onto the pre-column. If large sample volume is
applied, more frequent replacement of the SPS precolumn is needed. This is consistent with our observations with the SPS pre-column. Detection limits
may also be improved by use of microbore column
(i.e., 1.0 mm I.D.) for chiral separation because of its
compatible flow-rate, low void volume and high
separation efficiency.
Recovery studies of THP, biperiden, procyclidine,
and internal standard were carried out by injecting
both serum and aqueous standards into the on-line

SPE and LC–ESI-MS system. The results shown in
Table 2 were obtained by comparing the peak areas
of a serum standard with the corresponding peak
areas of an aqueous standard at the same concentration level. These results showed that the absolute
recoveries ranged 98.4–100.4% with relative standard deviations (RSDs) of 2.2–8.6%. The recoveries
indicated that the compounds being studied either did
not bind to serum proteins or their binding to serum
proteins was disrupted by the SPS pre-column.
Hypothetically, the binding of drug to serum proteins
is governed by chemical equilibrium. When the
serum sample containing drug molecule is loaded
onto the SPS pre-column, the unbound drug partitions in the hydrophobic internal stationary phase
whereas the protein-bound drug resides in the mobile
phase because of the exclusion of the large protein
molecules from the packing material pores. New
equilibrium between the bound and unbound drug
molecules follows the addition of fresh eluent that
carry the drug molecules to the next portion of the
‘‘naked’’ stationary phase. In accordance with their
distribution coefficients, the unbound drug again
resides in the hydrophobic internal stationary phase
and the bound drug in the mobile phase. As the

Table 2
Absolute recoveries of diphenidol, THP, biperiden and procyclidine from human serum
% Absolute recovery

Diphenidol (I.S.)
THP
Biperiden
Procyclidine

First peak

RSD (%)

Second peak

RSD (%)

98.4
100.1
99.8
100.4

7.3
7.6
4.9
8.5

101.4
101.3
100.4

3.4
2.2
6.7

Analyte enantiomer concentrations, 50 ng / ml each drug hydrochloride, n53.
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Table 3
Intra- and inter-assay reproducibility data (n56)
Intra-assay

THP/ I.S.
Biperiden / I.S.
Procyclidine / I.S.
a

Inter-assay

First peak

RSD (%)

Second peak

RSD (%)

First peak

RSD (%)

Second peak

RSD (%)

0.7960.07
0.3860.03
1.0860.05

6.4
8.8
4.5

0.7560.04
0.3460.03
0.9460.06

4.4
7.5
6.2

0.8160.08
0.3660.03
1.0360.08

8.8
9.7
8.1

0.7360.08
0.3360.03
0.9360.05 a

8.6
10.6
5.5 a

n55.

result of this ongoing process, the protein-bound
drug can be released and drug-free serum proteins
can be excluded from the SPS pre-column. This
hypothesis was previously studied by Hermansson et
al. [20,21] and their data along with the recovery
data of our previous work [25] supported the theory.
The intra- and inter-assay reproducibilities of the
method were evaluated and the data are shown in
Table 3. The intra-assay reproducibility was studied
by multiple injections of the same sample; whereas
the inter-assay reproducibility was based on the
injections of identically prepared samples. The results showed that the RSDs of all enantiomers were
#8.8% (except for one case where the RSD was
10.6%). The good reproducibility might be attributed
to the minimal sample handling.
The method developed can be easily automated by
replacing the manual Rheodyne 7000 two-position
six-port switching valve with a commercially available electronic switching valve. The system operation can be streamlined to increase sample throughput. After initial sample injection, the subsequent
on-line sample extractions and analytical separations
can be conducted in parallel. For example, 15 min
after the initial injection, the switching valve can be
switched back from position B to position A, and the
second sample can be extracted before the first
analytical separation is completed. Consequently, the
total run-time can be shortened.

Conclusions
A simple and quantitative LC–MS method for the
determination of enantiomers of THP, biperiden and
procyclidine in human serum has been developed.
The method has a wide dynamic range, low detection
limits, good reproducibility, and excellent recovery.

It is well suited for clinical, toxicological, and
pharmacological analyses where the simultaneous
analysis of the above compounds is needed. The
method uses on-line sample extraction that replaces
the conventional time-consuming sample preparations. The method can be easily automated for
increased sample throughput and unattended analyses.
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